Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC GLENMARK PHARMA ALEMBIC/
GLENMARK PHARMA
 
P/E (TTM) x 26.5 13.5 196.4% View Chart
P/BV x 0.8 1.3 58.4% View Chart
Dividend Yield % 2.4 0.6 407.3%  

Financials

 ALEMBIC   GLENMARK PHARMA
EQUITY SHARE DATA
    ALEMBIC
Mar-22
GLENMARK PHARMA
Mar-22
ALEMBIC/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs143691 20.8%   
Low Rs72416 17.3%   
Sales per share (Unadj.) Rs3.0436.1 0.7%  
Earnings per share (Unadj.) Rs3.435.2 9.5%  
Cash flow per share (Unadj.) Rs3.552.5 6.8%  
Dividends per share (Unadj.) Rs1.802.50 72.0%  
Avg Dividend yield %1.70.5 369.9%  
Book value per share (Unadj.) Rs97.2321.4 30.2%  
Shares outstanding (eoy) m256.78282.17 91.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x35.31.3 2,786.4%   
Avg P/E ratio x32.115.7 204.2%  
P/CF ratio (eoy) x30.410.5 288.0%  
Price / Book Value ratio x1.11.7 64.3%  
Dividend payout %53.67.1 755.3%   
Avg Mkt Cap Rs m27,643156,067 17.7%   
No. of employees `000NANA-   
Total wages/salary Rs m21524,474 0.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m782123,049 0.6%  
Other income Rs m8921,667 53.5%   
Total revenues Rs m1,674124,716 1.3%   
Gross profit Rs m13920,594 0.7%  
Depreciation Rs m494,867 1.0%   
Interest Rs m42,981 0.1%   
Profit before tax Rs m97914,412 6.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1174,476 2.6%   
Profit after tax Rs m8629,936 8.7%  
Gross profit margin %17.816.7 106.4%  
Effective tax rate %11.931.1 38.4%   
Net profit margin %110.28.1 1,364.6%  
BALANCE SHEET DATA
Current assets Rs m1,43382,823 1.7%   
Current liabilities Rs m67846,894 1.4%   
Net working cap to sales %96.629.2 330.8%  
Current ratio x2.11.8 119.8%  
Inventory Days Days10,3466 160,211.0%  
Debtors Days Days71092 772.2%  
Net fixed assets Rs m24,88671,148 35.0%   
Share capital Rs m514282 182.0%   
"Free" reserves Rs m24,45290,421 27.0%   
Net worth Rs m24,96690,703 27.5%   
Long term debt Rs m025,717 0.0%   
Total assets Rs m26,320153,972 17.1%  
Interest coverage x252.65.8 4,328.6%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x00.8 3.7%   
Return on assets %3.38.4 39.2%  
Return on equity %3.511.0 31.5%  
Return on capital %3.914.9 26.3%  
Exports to sales %2.00-   
Imports to sales %0.30-   
Exports (fob) Rs m16NA-   
Imports (cif) Rs m2NA-   
Fx inflow Rs m1632,142 0.0%   
Fx outflow Rs m213,482 0.0%   
Net fx Rs m1318,660 0.1%   
CASH FLOW
From Operations Rs m-17711,087 -1.6%  
From Investments Rs m188-3,333 -5.7%  
From Financial Activity Rs m-58-5,205 1.1%  
Net Cashflow Rs m-472,724 -1.7%  

Share Holding

Indian Promoters % 70.9 46.7 151.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.0 34.1 14.5%  
FIIs % 0.8 23.1 3.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 53.4 54.6%  
Shareholders   83,612 313,540 26.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    


More on ALEMBIC vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC vs Glenmark Pharma Share Price Performance

Period ALEMBIC Glenmark Pharma S&P BSE HEALTHCARE
1-Day 1.74% 0.20% -0.29%
1-Month 6.20% 3.10% -2.18%
1-Year -24.81% -14.70% -5.80%
3-Year CAGR 12.83% 9.09% 20.89%
5-Year CAGR 13.28% -4.50% 11.43%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of ALEMBIC hold a 70.9% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC paid a dividend of Rs 1.8 per share. This amounted to a Dividend Payout ratio of 53.6%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 7.1%.

You may visit here to review the dividend history of ALEMBIC, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 320 Points| PolicyBazaar Stake Sale| Oil & Gas and Auto Stocks Witness Most Selling(10:30 am)

Indian share markets opened on a negative note today halting their eight-day rally, amid a weak trend in global markets.